Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Long-Term Debt Issuances (2016 - 2024)

Biovie (BIVI) posted Long-Term Debt Issuances of $2.5 million for Q4 2024, little changed sequentially from $2.5 million in Q3 2024, and little changed YoY from $2.5 million in Q1 2024.

Biovie (BIVI) Long-Term Debt Issuances (2016 - 2024) Analysis & Trends

Biovie has reported Long-Term Debt Issuances for 7 years, with the latest figure at $2.5 million in Q4 2024.

  • Quarterly Long-Term Debt Issuances changed 0.0% year-over-year to $2.5 million in Q4 2024, while the trailing twelve-month figure through Jun 2025 was $5.0 million (down 50.0% YoY) and the FY2025 annual result came in at $5.0 million, down 50.0% from the prior year.
  • Long-Term Debt Issuances was little changed at $2.5 million in Q4 2024 per BIVI's latest filing, from $2.5 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $14.6 million in Q3 2022 and troughed at -$369500.0 in Q2 2020.
  • A 4-year average of $3.3 million and a median of $2.5 million in 2023 frame the typical range for Long-Term Debt Issuances.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Debt Issuances sank 82.89% in 2023, then changed 0.0% in 2024.
  • Over 4 years, Long-Term Debt Issuances stood at -$369500.0 in 2020, then surged by 4053.97% to $14.6 million in 2022, then tumbled by 82.89% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $2.5 million, $2.5 million, and $2.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Biovie 14.17 Mn 14.17 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.50 Mn
Dec 31, 2024 2.50 Mn
Sep 30, 2024 2.50 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Mar 31, 2024 2.50 Mn
Mar 31, 2024 2.50 Mn
Dec 31, 2023 2.50 Mn
Dec 31, 2023 2.50 Mn
Sep 30, 2023 2.50 Mn
Sep 30, 2023 2.50 Mn
Sep 30, 2022 14.61 Mn
Sep 30, 2022 14.61 Mn
Jun 30, 2020 -369,500.00
Jun 30, 2020 -369,500.00
Mar 31, 2020 402,000.00
Mar 31, 2020 402,000.00
Dec 31, 2018 264,000.00
Dec 31, 2018 264,000.00